Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Stanfield

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|June 10, 1994
Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivoP M O'Brien, D R Sliskovic, C J Blankley, et al.
Proteins|December 1, 1992
Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120E A Stura, R L Stanfield, G G Fieser, et al.
Bioorganic & Medicinal Chemistry|January 1, 1995
Bioisosterism in drug design: identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitorsW H Roark, J Padia, G L Bolton, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidatesH T Lee, W H Roark, J A Picard, et al.
Journal of Medicinal Chemistry|May 27, 1994
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activityB K Trivedi, T S Purchase, A Holmes, et al.
Journal of Medicinal Chemistry|March 4, 1994
Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 6. The first water-soluble ACAT inhibitor with lipid-regulating activityD R Sliskovic, B R Krause, J A Picard, et al.
Journal of Molecular Biology|October 26, 1999
Roles for glycosylation of cell surface receptors involved in cellular immune recognitionP M Rudd, M R Wormald, R L Stanfield, et al.
Journal of Medicinal Chemistry|October 1, 1993
Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agentsC E Augelli-Szafran, C J Blankley, B D Roth, et al.
Science (New York, N.Y.)|August 11, 2001
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine designE O Saphire, P W Parren, R Pantophlet, et al.
Journal of Medicinal Chemistry|May 1, 1992
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agentsB D Roth, C J Blankley, M L Hoefle, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|June 10, 1994
Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivoP M O'Brien, D R Sliskovic, C J Blankley, et al.
Proteins|December 1, 1992
Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120E A Stura, R L Stanfield, G G Fieser, et al.
Bioorganic & Medicinal Chemistry|January 1, 1995
Bioisosterism in drug design: identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitorsW H Roark, J Padia, G L Bolton, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidatesH T Lee, W H Roark, J A Picard, et al.
Journal of Medicinal Chemistry|May 27, 1994
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activityB K Trivedi, T S Purchase, A Holmes, et al.
Journal of Medicinal Chemistry|March 4, 1994
Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 6. The first water-soluble ACAT inhibitor with lipid-regulating activityD R Sliskovic, B R Krause, J A Picard, et al.
Journal of Molecular Biology|October 26, 1999
Roles for glycosylation of cell surface receptors involved in cellular immune recognitionP M Rudd, M R Wormald, R L Stanfield, et al.
Journal of Medicinal Chemistry|October 1, 1993
Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agentsC E Augelli-Szafran, C J Blankley, B D Roth, et al.
Science (New York, N.Y.)|August 11, 2001
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine designE O Saphire, P W Parren, R Pantophlet, et al.
Journal of Medicinal Chemistry|May 1, 1992
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agentsB D Roth, C J Blankley, M L Hoefle, et al.
Pageof 5